|
Jonathan W. Friedberg, MD, is Associate Professor of Medicine and Oncology at the
University
of
Rochester
, and director for hematological malignancies clinical research at the
James
P.
Wilmot
Cancer
Center
, in
Rochester, NY
. He also serves as Director of Inpatient Hematology Services. He is a member of the lymphoma committee in the Southwest Oncology Group, and serves as principal investigator on many local and national lymphoma treatment protocols. He is an attending physician at
Strong
Memorial
Hospital
, on the hematological malignancies and blood and marrow transplant service.
Dr. Friedberg received his medical degree from
Harvard
Medical
School
. His postgraduate training included an internship and residency at
Massachusetts General
Hospital
. He also completed a medical oncology and hematology fellowship at Dana-Farber/Partners Cancer Care in
Boston
. He is board certified in Internal Medicine and holds subspecialty certification in Medical Oncology and Hematology.
Dr. Friedberg was a clinical scholar of the Lymphoma Research Foundation, and holds a Career Development Award from the National Cancer Institute. He is Scientific Director of the NCCN Lymphoma Clinical Outcomes Database, and chair of the National Lymphomacare Study advisory board. He coordinates many local and national protocols studying novel therapies for patients with non-Hodgkin’s lymphoma and Hodgkin’s lymphoma.
|
